title: [Amiodarone treatment against atrial fibrillation caused thyrotoxicosis].
authors.affiliation: Endokrinologiska sektionen, medicinkliniken, Södersjukhuset. david.nathanson@sodersjukhuset.se
authors.forename: David
authors.initials: D
authors.lastname: Nathanson
authors.forename: Jan
authors.initials: J
authors.lastname: Calissendorff
authors.forename: Cecilia
authors.initials: C
authors.lastname: Lindhe
authors.forename: Sven
authors.initials: S
authors.lastname: Röjdmark
mesh_terms: D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013971:Thyrotoxicosis / Q000139:chemically induced*
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone